Persistence key in treating depression

Persistence key in treating depression

Science Daily (press release) - Nov 1, 2006... UCLA-led Study Challenges Bipolar Depression Treatment Guidelines (July 2, 2003) -- A study led by a UCLA Neuropsychiatric Institute researcher challenges ...
Source: www.sciencedaily.com

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...
DG News - Nov 17, 2006... Beyond schizophrenia, bipolar mania and bipolar depression, the ongoing clinical development ... Regulatory filings for the treatment of schizophrenia with a ...
Source: www.docguide.com

Click here for more information about cause of depression cause of depression

The Treatment of Elderly Patients With Bipolar Disorder CME/CE

The Treatment of Elderly Patients With Bipolar Disorder CME/CE

Medscape News - Lamotrigine use in geriatric patients with bipolar depression. Can J Psychiatry. 2002;47:767-770. Abstract Sajatovic M, Gyulai L, Calabrese JR, et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry
Source: www.medscape.com

Mentally ill Focus of Show
Ledger - LAKELAND -- Lakeland resident Risdon Slate's experience with bipolar depression and his comments on mental illness are scheduled criminology program, is a veteran advocate for people with mental illnesses and their ability, with good treatment and
Source: www.theledger.com


Click here for more information about beck depression inventory beck depression inventory

The Treatment of Elderly Patients With Bipolar Disorder CME/CE

The Treatment of Elderly Patients With Bipolar Disorder CME/CE

Medscape News - Lamotrigine use in geriatric patients with bipolar depression. Can J Psychiatry. 2002;47:767-770. Abstract Sajatovic M, Gyulai L, Calabrese JR, et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry
Source: www.medscape.com

FDA Gives OK for Schizophrenia Treatment
KFMB - Co.'s Abilify are intended to have fewer side effects and dominate a market worth around $16.2 billion. The FDA decision to approve the new treatment in the United States was based on an eight-week study of 1,045 patients with bipolar depression.
Source: www.kfmb.com

Mentally ill Focus of Show
Ledger - LAKELAND -- Lakeland resident Risdon Slate's experience with bipolar depression and his comments on mental illness are scheduled criminology program, is a veteran advocate for people with mental illnesses and their ability, with good treatment and
Source: www.theledger.com


Click here for more information about depression clinic depression clinic

New hope for manic-depression sufferers comes from unlikely source

New hope for manic-depression sufferers comes from unlikely source

Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results
Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

Using Pramipexole in Neuropsychiatry: A Cautionary Note
Journal of Neuropsychiatry (subscription) - Nov 29, 2006... CJ: Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers to treat treatment resistant bipolar depression. ...
Source: neuro.psychiatryonline.org

New Hope for Manic-Depression Sufferers Comes from Unlikely Source
PharmaLive.com (press release), PA - Nov 21, 2006... because Seroquel has been shown to significantly alleviate bipolar depression, but also ... phase of the disorder, however, little acute treatment was available ...
Source: www.pharmalive.com

Click here for more information about cause of depression cause of depression

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...

DG News - Nov 17, 2006... Beyond schizophrenia, bipolar mania and bipolar depression, the ongoing clinical development ... Regulatory filings for the treatment of schizophrenia with a ...
Source: www.docguide.com

New hope for manic-depression sufferers comes from unlikely source
Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

AstraZeneca Takes A Big Step In Fight Against Bipolar Disorder
Investor's Business Daily (subscription) - Nov 3, 2006... By 2011, sales should hit $6.2 billion. Most of the added sales over the next few years should come from orders tied to treatment of bipolar depression. ...
Source: www.investors.com

Older Antipsychotic Drugs As Effective As Newer Ones
HealthNewsDigest.com, NY - Nov 19, 2006... routine use of antipsychotics to treat people with bipolar depression in light of ... Generic perphenazine � as initial treatment for people newly diagnosed with ...
Source: healthnewsdigest.com

AstraZeneca Under Legal Fire Over Seroquel
Newsinferno.com, NY - Oct 31, 2006... In 2005, sales of Seroquel totaled about $2.76 billion. Earlier this month, the FDA officially approved the drug for the treatment of bipolar depression. ...
Source: www.newsinferno.com

Click here for more information about childhood depression childhood depression

AstraZeneca Takes A Big Step In Fight Against Bipolar Disorder

AstraZeneca Takes A Big Step In Fight Against Bipolar Disorder

Investor's Business Daily (subscription) - Nov 3, 2006... By 2011, sales should hit $6.2 billion. Most of the added sales over the next few years should come from orders tied to treatment of bipolar depression. ...
Source: www.investors.com

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results
Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

Time for a Change
About - News & Issues, NY - Nov 9, 2006... He replied that the #1 drug in his opinion for bipolar depression is Lamictal ... A side effect more common than rash when initiating Lamictal treatment, he said ...
Source: bipolar.about.com

New Hope for Manic-Depression Sufferers Comes from Unlikely Source
PharmaLive.com (press release), PA - Nov 21, 2006... because Seroquel has been shown to significantly alleviate bipolar depression, but also ... phase of the disorder, however, little acute treatment was available ...
Source: www.pharmalive.com

AstraZeneca Under Legal Fire Over Seroquel
Newsinferno.com, NY - Oct 31, 2006... In 2005, sales of Seroquel totaled about $2.76 billion. Earlier this month, the FDA officially approved the drug for the treatment of bipolar depression. ...
Source: www.newsinferno.com

Click here for more information about manic depression manic depression

MALCOM BERKO: Educate yourself on paying for college

MALCOM BERKO: Educate yourself on paying for college

Wilmington Morning Star - Repligen Corp. (RGEN) develops therapeutics for the treatment of diseases affecting the central nervous system. RGEN has two impressive products in clinical trials (for schizophrenia and bipolar depression) that could have enormous revenue potential
Source: www.wilmingtonstar.com

Mentally ill Focus of Show
Ledger - LAKELAND -- Lakeland resident Risdon Slate's experience with bipolar depression and his comments on mental illness are scheduled criminology program, is a veteran advocate for people with mental illnesses and their ability, with good treatment and
Source: www.theledger.com

Treatment-Resistant Depression: Diagnostic Strategies and Current
Medscape News - Misdiagnosis also includes failure to identify the actual subtype of mood disorder, which is common, as is ruling out a diagnosis of atypical, psychotic, or bipolar depression. All of these considerations have an impact on treatment selection. In
Source: www.medscape.com


Click here for more information about bipolar depression symptom bipolar depression symptom

New hope for manic-depression sufferers comes from unlikely source

New hope for manic-depression sufferers comes from unlikely source

Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Click here for more information about severe depression severe depression

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

Click here for more information about anxiety depression anxiety depression

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

Older Antipsychotic Drugs As Effective As Newer Ones
HealthNewsDigest.com, NY - Nov 19, 2006... routine use of antipsychotics to treat people with bipolar depression in light of ... Generic perphenazine � as initial treatment for people newly diagnosed with ...
Source: healthnewsdigest.com

Click here for more information about anxiety depression anxiety depression

Omega-3 Fatty Acids and Mood Disorders

Omega-3 Fatty Acids and Mood Disorders

Am J Psychiatry (subscription) - Oct 30, 2006... both studies, 6 grams of eicosapentaenoic acid were added to ongoing treatment. In the first study, 59 patients with an acute bipolar depression were treated ...
Source: ajp.psychiatryonline.org

New hope for manic-depression sufferers comes from unlikely source
Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

AstraZeneca Under Legal Fire Over Seroquel
Newsinferno.com, NY - Oct 31, 2006... In 2005, sales of Seroquel totaled about $2.76 billion. Earlier this month, the FDA officially approved the drug for the treatment of bipolar depression. ...
Source: www.newsinferno.com

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...
DG News - Nov 17, 2006... Beyond schizophrenia, bipolar mania and bipolar depression, the ongoing clinical development ... Regulatory filings for the treatment of schizophrenia with a ...
Source: www.docguide.com

Click here for more information about depression help depression help

Older Antipsychotic Drugs As Effective As Newer Ones

Older Antipsychotic Drugs As Effective As Newer Ones

HealthNewsDigest.com, NY - Nov 19, 2006... routine use of antipsychotics to treat people with bipolar depression in light of ... Generic perphenazine � as initial treatment for people newly diagnosed with ...
Source: healthnewsdigest.com

Using Pramipexole in Neuropsychiatry: A Cautionary Note
Journal of Neuropsychiatry (subscription) - 3 hours ago... CJ: Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers to treat treatment resistant bipolar depression. ...
Source: neuro.psychiatryonline.org

New hope for manic-depression sufferers comes from unlikely source
Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Click here for more information about depression screening depression screening

New hope for manic-depression sufferers comes from unlikely source

New hope for manic-depression sufferers comes from unlikely source

Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...
DG News - Nov 17, 2006... Beyond schizophrenia, bipolar mania and bipolar depression, the ongoing clinical development ... Regulatory filings for the treatment of schizophrenia with a ...
Source: www.docguide.com

Omega-3 Fatty Acids and Mood Disorders
Am J Psychiatry (subscription) - Oct 30, 2006... both studies, 6 grams of eicosapentaenoic acid were added to ongoing treatment. In the first study, 59 patients with an acute bipolar depression were treated ...
Source: ajp.psychiatryonline.org

AstraZeneca Under Legal Fire Over Seroquel
Newsinferno.com, NY - Oct 31, 2006... In 2005, sales of Seroquel totaled about $2.76 billion. Earlier this month, the FDA officially approved the drug for the treatment of bipolar depression. ...
Source: www.newsinferno.com

Persistence key in treating depression
Science Daily (press release) - Nov 1, 2006... UCLA-led Study Challenges Bipolar Depression Treatment Guidelines (July 2, 2003) -- A study led by a UCLA Neuropsychiatric Institute researcher challenges ...
Source: www.sciencedaily.com

Click here for more information about depression chat room depression chat room

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

New hope for manic-depression sufferers comes from unlikely source
Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Click here for more information about depression support group depression support group

New hope for manic-depression sufferers comes from unlikely source

New hope for manic-depression sufferers comes from unlikely source

Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Time for a Change
About - News & Issues, NY - Nov 9, 2006... He replied that the #1 drug in his opinion for bipolar depression is Lamictal ... A side effect more common than rash when initiating Lamictal treatment, he said ...
Source: bipolar.about.com

Click here for more information about zoloft depression medication zoloft depression medication

Time for a Change

Time for a Change

About - News & Issues, NY - Nov 9, 2006... He replied that the #1 drug in his opinion for bipolar depression is Lamictal ... A side effect more common than rash when initiating Lamictal treatment, he said ...
Source: bipolar.about.com

New hope for manic-depression sufferers comes from unlikely source
Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Click here for more information about physical symptom of depression physical symptom of depression

AstraZeneca Under Legal Fire Over Seroquel

AstraZeneca Under Legal Fire Over Seroquel

Newsinferno.com, NY - Oct 31, 2006... In 2005, sales of Seroquel totaled about $2.76 billion. Earlier this month, the FDA officially approved the drug for the treatment of bipolar depression. ...
Source: www.newsinferno.com

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results
Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...
DG News - Nov 17, 2006... Beyond schizophrenia, bipolar mania and bipolar depression, the ongoing clinical development ... Regulatory filings for the treatment of schizophrenia with a ...
Source: www.docguide.com

New Hope for Manic-Depression Sufferers Comes from Unlikely Source
PharmaLive.com (press release), PA - Nov 21, 2006... because Seroquel has been shown to significantly alleviate bipolar depression, but also ... phase of the disorder, however, little acute treatment was available ...
Source: www.pharmalive.com

Time for a Change
About - News & Issues, NY - Nov 9, 2006... He replied that the #1 drug in his opinion for bipolar depression is Lamictal ... A side effect more common than rash when initiating Lamictal treatment, he said ...
Source: bipolar.about.com

Click here for more information about treating depression treating depression

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...

DG News - Nov 17, 2006... Beyond schizophrenia, bipolar mania and bipolar depression, the ongoing clinical development ... Regulatory filings for the treatment of schizophrenia with a ...
Source: www.docguide.com

AstraZeneca Takes A Big Step In Fight Against Bipolar Disorder
Investor's Business Daily (subscription) - Nov 3, 2006... By 2011, sales should hit $6.2 billion. Most of the added sales over the next few years should come from orders tied to treatment of bipolar depression. ...
Source: www.investors.com

Click here for more information about depression statistics depression statistics

AstraZeneca Takes A Big Step In Fight Against Bipolar Disorder

AstraZeneca Takes A Big Step In Fight Against Bipolar Disorder

Investor's Business Daily (subscription) - Nov 3, 2006... By 2011, sales should hit $6.2 billion. Most of the added sales over the next few years should come from orders tied to treatment of bipolar depression. ...
Source: www.investors.com

Click here for more information about clinical depression symptom clinical depression symptom

Omega-3 Fatty Acids and Mood Disorders

Omega-3 Fatty Acids and Mood Disorders

Am J Psychiatry (subscription) - Oct 30, 2006... both studies, 6 grams of eicosapentaenoic acid were added to ongoing treatment. In the first study, 59 patients with an acute bipolar depression were treated ...
Source: ajp.psychiatryonline.org

Click here for more information about seasonal depression seasonal depression

AstraZeneca shares take a tumble

AstraZeneca shares take a tumble

The News Journal, DE - Oct 27, 2006... Sales of Seroquel, which the Food and Drug Administration last week approved for the treatment of bipolar depression, climbed 19 percent to $848 million. ...
Source: www.delawareonline.com

New hope for manic-depression sufferers comes from unlikely source
Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

FDA Gives OK for Schizophrenia Treatment
KFMB, CA - Oct 24, 2006... The FDA decision to approve the new treatment in the United States was based on an eight-week study of 1,045 patients with bipolar depression. ...
Source: www.kfmb.com

US approves Seroquel for bipolar depression
Pharmaceutical Business Review - Oct 23, 2006... of bipolar disorder, has now been approved in the US for bipolar depression, making it ... of the illness can be crucial to the overall treatment process," said ...
Source: www.pharmaceutical-business-review.com

Click here for more information about clinical depression symptom clinical depression symptom

A quick education on paying for college

A quick education on paying for college

The Courier News, IL - Nov 2, 2006... the treatment of diseases affecting the central nervous system. RGEN has two impressive products in clinical trials (for schizophrenia and bipolar depression) ...
Source: www.suburbanchicagonews.com

Lilly Reports 7% Sales Growth, 10% Earnings Growth and $.80 EPS ...
Drug Newswire (press release), CT - Oct 24, 2006... remission despite adequate antidepressant therapy. Symbyax is already approved in the US for the treatment of bipolar depression. ...
Source: www.drugnewswire.com

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results
Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

New hope for manic-depression sufferers comes from unlikely source
Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Click here for more information about beck depression inventory beck depression inventory

AstraZeneca shares take a tumble

AstraZeneca shares take a tumble

The News Journal, DE - Oct 27, 2006... Sales of Seroquel, which the Food and Drug Administration last week approved for the treatment of bipolar depression, climbed 19 percent to $848 million. ...
Source: www.delawareonline.com

AstraZeneca Takes A Big Step In Fight Against Bipolar Disorder
Investor's Business Daily (subscription) - Nov 3, 2006... By 2011, sales should hit $6.2 billion. Most of the added sales over the next few years should come from orders tied to treatment of bipolar depression. ...
Source: www.investors.com

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results
Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

Persistence key in treating depression
Science Daily (press release) - Nov 1, 2006... UCLA-led Study Challenges Bipolar Depression Treatment Guidelines (July 2, 2003) -- A study led by a UCLA Neuropsychiatric Institute researcher challenges ...
Source: www.sciencedaily.com

Drug firms hit by development snags
Guardian Unlimited, UK - Oct 26, 2006... The group's five main drugs, which include the ulcer treatment Nexium, and Seroquel, a treatment against bipolar depression, performed well. ...
Source: www.guardian.co.uk

Click here for more information about depression screening depression screening

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Repligen Reports Second Quarter Fiscal Year 2007 Financial Results

Yahoo! News (press release) - Nov 2, 2006... a Phase 2 clinical trial of RG2417, an oral formulation of uridine in bipolar depression. ... and biotechnology companies, new approaches to the treatment of our ...
Source: biz.yahoo.com

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...
DG News - Nov 17, 2006... Beyond schizophrenia, bipolar mania and bipolar depression, the ongoing clinical development ... Regulatory filings for the treatment of schizophrenia with a ...
Source: www.docguide.com

FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression ...
Drug Newswire (press release), CT - Oct 24, 2006... eight weeks of treatment with fixed doses of SEROQUEL(R) (300 mg or 600 mg) or placebo administered once-daily. Efficacy in bipolar depression was demonstrated ...
Source: www.drugnewswire.com

Click here for more information about women and depression women and depression

New hope for manic-depression sufferers comes from unlikely source

New hope for manic-depression sufferers comes from unlikely source

Pharmaceutical Business Review - Nov 21, 2006... for bipolar depression, the global bipolar disorder market will continue to grow until 2011, when revenues will peak at $6.6 billion. Current treatment for ...
Source: www.pharmaceutical-business-review.com

Time for a Change
About - News & Issues, NY - Nov 9, 2006... He replied that the #1 drug in his opinion for bipolar depression is Lamictal ... A side effect more common than rash when initiating Lamictal treatment, he said ...
Source: bipolar.about.com

Click here for more information about information on depression information on depression